Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04321720
Other study ID # SWI_12
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 20, 2020
Est. completion date August 26, 2020

Study information

Verified date September 2020
Source ARCIM Institute Academic Research in Complementary and Integrative Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A study to explore whether different dosages of mustard flour in footbaths cause different effects on warmth development as well as on general well-being and the autonomic nervous system.


Description:

This is a blinded, four-arm randomized controlled trial with crossover design to explore the dose-response relationship of footbaths with different dosages of mustard flour in healthy volunteers, compared to a placebo control (footbath with warm water only). The main focus is on thermogenesis and warmth distribution, as assessed by high-resolution infrared thermography and questionnaire data before, during and after the intervention. In addition, effects on the autonomic nervous system are assessed by measuring various parameters of heart rate variability and pulse wave analysis.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date August 26, 2020
Est. primary completion date August 25, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- Written informed consent;

- Age between 18 and 55 years

Exclusion Criteria:

- Chronic skin lesions at the lower legs or feet

- Varicose veins grade 3 and grade 4 (Marshall stage classification)

- Chronic venous insufficiency

- Known intolerance or hypersensitivity to mustard preparations

- Cardiac arrhythmia

- Cardiac pacemaker

- Asthma bronchiale

- Consumption of HRV-modulating medication (especially tricyclic antidepressants, beta blockers)

- Pregnancy

- Insufficient knowledge of the german language

Study Design


Related Conditions & MeSH terms

  • Thermogenesis by Different-dosage Mustard Flour Footbaths

Intervention

Other:
3-g mustard footbath
A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 36 g mustard flour (3 g per l), followed by a ten-minute post-intervention rest period.
6-g mustard footbath
A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 72 g mustard flour (6 g per l), followed by a ten-minute post-intervention rest period.
12-g mustard footbath
A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 144 g mustard flour (12 g per l), followed by a ten-minute post-intervention rest period.
Warm water only
A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C), followed by a ten-minute post-intervention rest period.

Locations

Country Name City State
Germany Arcim Institute Filderstadt Baden-Württemberg

Sponsors (2)

Lead Sponsor Collaborator
ARCIM Institute Academic Research in Complementary and Integrative Medicine University Hospital Tuebingen

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary 2-item warmth perception measure at the feet after the footbath Self-reported warmth perception at both feet, assessed with the "Herdecke warmth perception questionnaire" immediately after the footbath (t2). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4. Immediately after the footbath, timepoint 2 (t2)
Secondary 2-item warmth perception measure at the feet at time point 1 (t1) and time point 3 (t3) Self-reported warmth perception at both feet, assessed with the "Herdecke warmth perception questionnaire" immediately before (t1) and 10 minutes following the footbath (t3). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4. Immediately before (time point 1, t1) and 10 minutes following the footbath (time point 3, t3).
Secondary 2-item warmth perception measure at the hands at t1, t2 and t3 Self-reported warmth perception at both hands, assessed with the "Herdecke warmth perception questionnaire" immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4. Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3).
Secondary 2-item warmth perception measure at the head at t1, t2 and t3 Self-reported warmth perception at the head, assessed with the "Herdecke warmth perception questionnaire" immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4. Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3)
Secondary 1-item overall warmth perception measure at t1, t2 and t3 Self-reported overall warmth perception, assessed with the "Herdecke warmth perception questionnaire" immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3). The item is scored 0-4 (0 = cold; 4 = hot). Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3)
Secondary Warmth perception and skin stimulus at the feet during the footbath Self-reported perception of warmth and skin stimulus during the footbath, assessed with a dynamic warmth and skin stimulus visual analog scale (VAS), applied once per minute (0 = cold/no stimulus; 10 = very hot/very strong stimulus). Up to 20 minutes
Secondary Well-being at t1, t2 and t3 Self-reported well-being, assessed with the "Basler Befindlichkeits-Skala" (Basel Mood Questionnaire, BBS) immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3). (BBS: 16 items; 7-point rating scale; higher values represent a better outcome.) Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3) (length of footbath is up to 20 minutes)
Secondary Skin surface temperature at the feet at t1, t2 and t3 Skin surface temperature (°C) at both feet, measured with high-resolution infrared thermography immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3) Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3)
Secondary Skin surface temperature at the lower legs at t1, t2 and t3 Skin surface temperature (°C) at both lower legs, measured with high-resolution infrared thermography immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3) Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3)
Secondary Skin surface temperature at the hands at t1, t2 and t3 Skin surface temperature (°C) at both hands, measured with high-resolution infrared thermography immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3) Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3)
Secondary Skin surface temperature in the face at t1, t2 and t3 Skin surface temperature (°C) in the face, measured with high-resolution infrared thermography immediately before (t1), immediately after (t2) and 10 minutes following the footbath (t3) Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3) (length of footbath is up to 20 minutes)
Secondary Heart rate variability (HRV) analysis: HF HF: High frequency power band (0.15-0.40 Hz) (ms2) from frequency domain analysis, obtained from ECG recordings throughout the intervention and the pre- and post-intervention rest periods (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary HRV analysis: LF LF: Low frequency power band (0.04-0.15 Hz) (ms2) from frequency domain analysis (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary HRV analysis: LF/HF ratio LF/HF ratio = ratio of two bands from frequency domain analysis: LF band (0.04-0.15 Hz), HF band (0.15-0.40 Hz) (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary HRV analysis: SDNN SDNN: Standard deviation of normal to normal (NN) intervals (ms) (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary HRV analysis: RMSSD RMSSD: Root mean square of successive differences (ms) (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary HRV analysis: pNN50 pNN50: Percentage of successive NN intervals that differ from each other by more than 50 ms (%) (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary Pulse wave analysis: Pulse Transit Time Pulse Transit Time (PTT, ms), obtained from pulse oximetry recordings throughout the intervention and the pre- and post-intervention rest periods (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary Pulse wave analysis: Reflection Index Reflection Index (RI, %, percent), obtained from pulse oximetry recordings throughout the intervention and the pre- and post-intervention rest periods (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary Pulse wave analysis: Perfusion Index Perfusion Index (PI, %, percent), obtained from pulse oximetry recordings throughout the intervention and the pre- and post-intervention rest periods (VitaGuard® 3100 monitor, getemed, Germany) Up to 40 minutes (continuous measurement from the beginning of the pre-intervention rest period to the end of the post-intervention rest-period)
Secondary Evening morning protocol: perception of warmth and stimulus at the feet Self-reported lasting effects of the footbaths at the feet, indicated on a seven-point rating scale (higher values represent a better outcome) After footbath in the evening, before going to sleep; on the following morning, within 15 minutes after waking up
Secondary Evening morning protocol: skin condition Self-reported lasting effects of the footbaths on skin condition, indicated on a seven-point rating scale (higher values represent a better outcome) After footbath in the evening, before going to sleep; on the following morning, within 15 minutes after waking up
Secondary Evening morning protocol: general well-being Self-reported lasting effects of the footbaths on general well-being, indicated on a seven-point rating scale (higher values represent a better outcome) After footbath in the evening, before going to sleep; on the following morning, within 15 minutes after waking up
Secondary Morning protocol: sleep quality: seven-point rating scale Self-reported sleep quality during the night following the footbaths, indicated on a seven-point rating scale (higher values represent a better outcome) In the morning after the footbath, within 15 minutes after waking up